Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN51028168
ISRCTN51028168
Completed
Not Applicable

A randomised clinical trial to compare the AV impulse foot pump with low molecular weight Heparin in the prevention of deep vein thrombosis after total knee replacement

HS R&D Regional Programme Register - Department of Health (UK)0 sites229 target enrollmentJanuary 23, 2004
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTotal knee replacementSurgery

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Total knee replacement
Sponsor
HS R&D Regional Programme Register - Department of Health (UK)
Enrollment
229
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 23, 2004
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
HS R&D Regional Programme Register - Department of Health (UK)

Eligibility Criteria

Inclusion Criteria

  • •Patients scheduled for unilateral primary total knee replacement at the Avon Orthopaedic Centre.

Exclusion Criteria

  • •1\. Refusal of consent
  • •2\. Long\-term warfarin therapy for pre\-existing cardiac or cerebral disease
  • •3\. A bleeding tendency
  • •4\. Painful joints or wounds in the feet which would preclude the use of the foot pump

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A randomised clinical trial to compare the AV impulse foot pump with low molecular weight Heparin in the prevention of deep vein thrombosis after total hip replacementCardiovascular diseases: Thromboembolic diseaseCirculatory SystemThromboembolic disease
ISRCTN17418323HS R&D Regional Programme Register - Department of Health (UK)290
Not yet recruiting
Phase 2
The effect of vitamin C on type 2 diabetes patient.
IRCT20180627040253N1Mashhad University of Medical Sciences54
Recruiting
Phase 1
The effectiveness of Allicin on survival of sepsis patients in intensive care unitsSepsis.Sepsis, unspecified organismA41.9
IRCT20220508054780N3Mashhad University of Medical Sciences110
Not yet recruiting
Phase 2
Ayurvedic treatment for pain, swelling and tenderness.Health Condition 1: M858- Other specified disorders of bonedensity and structure
CTRI/2021/03/031624Shree Jagadguru gavisidheswara ayurvedic medical college postgraduate studies and research centre
Completed
Phase 4
Intravenous midazolam-droperidol (combination), droperidol (only) or olanzapine (only) for the acutely agitated patient:A multi-centre, randomised, double-blind, controlled, clinical trial
ACTRN12614000980639Austin Hospital342